Background: The most common serious complication following acute ischemic stroke is pneumonia, which may increase mortality and worsen clinical outcomes. The purpose of this study was to investigate the predictors of 30-day mortality in patients with pneumonia following acute ischemic stroke. Methods: From June 2006 to May 2011, we retrospectively included 51 patients with pneumonia following acute ischemic stroke. We analyzed the clinical features, microbiologic data, and outcomes. Predictors of 30-day mortality were investigated by univariate and multivariate analysis. Results: The acute ischemic strokes were caused by large-artery atherosclerosis in 37 (72.5%) of the 51 patients. We found that the most common pathogen responsible for poststroke pneumonia was Klebsiella pneumoniae, followed by Pseudomonas aeruginosa and Escherichia coli. Ultimately, 12 patients died of progressive sepsis due to pneumonia after the acute ischemic stroke. The 30-day mortality rate was 23.5%. In the univariate analysis, patients who died within 30 days had higher National Institutes of Health Stroke Scale scores, higher CURB-65 scores, elevated instability of hemodynamic status, and lower Glasgow Coma Scale (GCS) scores. In Cox regression analysis, a GCS score of <9 on the day of pneumonia onset was only significant indicator for 30-day mortality (hazard ratio, 6.72; 95% confidence interval, 2.12e21.30, p ¼ 0.001). Conclusion: Pneumonia after acute ischemic stroke is a severe complication. Once stroke-related pneumonia develops, neurologic assessment, CURB-65 score, and shock can be used to predict the ultimate prognosis.
Introduction
Stroke is a major cause of mortality worldwide, particularly in middle and upper income countries. In the last 5 years, it is the third most common cause of death in Taiwan; the prevalence rate for stroke in 1986 in Taiwanese people 36 years of age or older was 1642 per 100,000 and the incidence rate for people aged 36 or older was 330 per 100,000. 1, 2 In 2008, 6.2 million people died of stroke or another form of cerebrovascular disease. 3 Although neurologic complications are the major causes of mortality, up to one-half of all patients with acute stroke may die of other medical complications, including pulmonary infection. 4 Among the non-neurologic complications of acute stroke, pneumonia is a common infective complication with a reported frequency of 10e20%. Once stroke-related pneumonia develops, the patients will usually have poor clinical outcome including increased long-term disability or mortality. 4, 5 One large cohort study reported that stroke patients complicated with pneumonia had a three-fold greater risk of 30-day mortality compared with those without pneumonia, and the population-attributable risk was 10%. 6 For patients with community-acquired pneumonia, several risk-stratified prediction rules for prognosis including pneumonia severity index (PSI) and CURB-65 score provide valuable predictive value for risk assessment and 30-day mortality. 7, 8 For patients with higher PSI (class V) or CURB-65 scores (4 or 5), the mortality rate is high (30e50%), and the physicians should carefully assess the patients for admission to intensive care units. However, limited research has been done to establish prognostic factors for the outcome of pneumonia following acute stroke.
In this study, we investigated the incidence of pneumonia following acute ischemic stroke and described the major identified pathogens. Furthermore, we analyzed the possible predictive factors for 30-day mortality.
Methods

Study population
National Yang-Ming University is a 400-bed regional teaching hospital and offers clinical services in North Yilan City. From June 2006 to May 2010, patients aged 18 years or older who were admitted to National Yang-Ming Hospital due to acute ischemic stroke were screened for eligibility for inclusion in this study. Exclusion criteria included those aged less than 18 years, those who died within 3 days after admission for acute stroke, those with acute hemorrhagic stroke, and those without chest plain film examinations upon admission (Fig. 1) . Neurologic status was assessed on a daily basis using the National Institutes of Health Stroke Scale (NIHSS). The final infarct location was determined using cranial computed tomography or magnetic resonance imaging.
The diagnosis of stroke was confirmed based on previously published and generally accepted clinical criteria. 9 Essentially, stroke was diagnosed if there was a new onset of neurologic deficits, corresponding to a vascular origin in the brain lasted for more than 24 hours. The subtype of acute ischemic stroke was classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST). 10 Pneumonia following stroke during the same hospitalization was diagnosed according to Centers for Disease Control and Prevention criteria. 11 Briefly, pneumonia was diagnosed if the patient had relevant clinical manifestations (fever, leukocytosis, or purulent tracheal secretion), positive microbiologic findings (blood, sputum cultures), and a new onset of pulmonary infiltrates on chest radiography. This information was submitted to a review committee comprised of two radiologists and two pulmonologists to confirm the diagnosis of pneumonia. The study was approved by the Institutional Review Board. Written informed consent was waived due to the retrospective design of the study.
Clinical data
Demographic, laboratory, and radiologic data of the study population were obtained from medical record records. Patient records for at least 30 days were reviewed unless death had previously occurred. The demographic data included age, sex, comorbidity, smoking history, and the Glasgow Coma Scale (GCS) 12 at the initial presentation of stroke and pneumonia. For each patient, the time from acute ischemic stroke to pneumonia was recorded. Laboratory data, including complete blood cell with differential counts, C-reactive protein (CRP), biochemistry, oxyhemoglobin saturation measured by pulse oximetry (SpO 2 ), and arterial blood gas analysis, were reviewed. The severity of pneumonia was assessed by PSI and CURB-65 score, and the PSI score based on age and coexisting disease, abnormal physical finding, and abnormal laboratory finding upon presentation. 7 The CURB-65 score based on confusion, urea, respiratory rate, blood pressure, and age at pneumonia presentation. 8 The causative microorganism of pneumonia was identified if the pathogen was isolated through blood culturing or pleural effusion. The predominant pathogen isolated from a sputum culture that corresponded to a Gram stain of the same sputum specimen was also considered to be a causative microorganism. Shock was defined as systolic blood pressure less than 90 mmHg for at least 30 minutes, which required vasopressor for at least 4 hours after adequate fluid replacement. 13 
Radiologic analysis
Brain computed tomography and magnetic resonance images and chest plain films were reviewed independently by two radiologists who were blinded to the clinical and epidemiologic data.
Statistical analysis
Statistical analyses were performed using SPSS software version 15.0 (SPSS Inc., Chicago, IL, USA). In each group, the patient data were described by frequency for categorical variables, and by mean AE standard deviation (SD) for numeric variables. The time from the day of stroke to pneumonia onset was described by median and range. Categoric variables were compared using the Chi-square test or Fisher's exact test, and continuous variables were compared using an independent unpaired t test and the Mann-Whitney U test if not normally distributed. Univariate analysis was performed to evaluate prognostic factors for 30-day mortality and Cox regression analysis was used to identify the predictors of 30-day mortality. A two-tailed p value <0.05 was considered to be statistically significant.
Results
Patient characteristics
From June 2006 to May 2010, 495 patients who were admitted due to acute ischemic stroke were included for further screening. Of these patients, 51 were diagnosed with pneumonia following stroke. The frequency of pneumonia following acute ischemic stroke was 10.3%.
The mean age of the 51 patients was 80.3 years and 37 (72.5%) were male. According to the TOAST classification, the acute ischemic strokes were due to large-artery atherosclerosis in 37 (72.5%) of the patients, followed by small vessel occlusion (n ¼ 11, 21.6%), cardioembolism (n ¼ 2, 3.9%), and undetermined etiology (n ¼ 1, 2.0%). The demographic data of the patients are summarized in Table 1 . The most common comorbidity was hypertension (70.6%).
The median time from stroke to pneumonia was 4.4 days (range: 0e23 days). In 27 (52.9%) patients, pneumonia occurred in the first 3 days after stroke occurred.
Microbiologic diagnostic data of pneumonia
The microbiologic data of poststroke pneumonia are summarized in Table 2 . The most common causative pathogen was Klebsiella pneumoniae (n ¼ 12), followed by Pseudomonas aeruginosa (n ¼ 5) and Escherichia coli (n ¼ 5).
Patient outcomes
The most common classification of PSI upon diagnosis of pneumonia was class IV (n ¼ 23, 45.1%), followed by class V (n ¼ 22, 43.1%) and class III (n ¼ 5, 9.8%). All patients received intravenous antibiotic treatment once pneumonia was diagnosed. Twelve patients died and the 30-day mortality rate was 23.5%. Regarding causes of death, 12 patients died of progressive sepsis due to pulmonary infection. The 30-day mortality rate according to the PSI classification was 36.4% (class V), 17.4% (class IV), and 0% (class III).
Of these patients, the CURB-65 scores are as follows: 1 (n ¼ 5, 9.8%), 2 (n ¼ 17, 33.3%), 3 (n ¼ 24, 40.1%), and 4 (n ¼ 5, 9.8%). The 30-day mortality rate for each CURB-65 score was 60% (score ¼ 4), 29.2% (score ¼ 3), 11.8% (score ¼ 2), and 0% (score ¼ 1).
The most common presentation on the chest radiograph was unilateral alveolar consolidation (56.9%). There were no statistically significant imaging pattern for the survival and nonsurvival groups (Table 3) .
The empirical antibiotics were classified as respiratory fluoroquinolone (levofloxacin), b-lactam (cefazolin, cefuroxime, cefoxitin, ceftriaxone, and ampicillin-sulbactam), and antipseudomonal b-lactam (ceftazidime and piperacillintazobactam). There were no statistical significance in initial antibiotic selection between the groups (Table 3) .
Univariate and Cox regression analysis for 30-day mortality
In univariate analysis, higher National Institutes of Health Stroke Scale scores, CURB-65 scores ! 3, lower GCS scores on the day of pneumonia onset, and shock were the predictors of 30-day mortality (Table 3) . In Cox regression analysis (Table 4) , a GCS score of less than 9 on the day of pneumonia onset was only significant indicator for 30-day mortality (hazard ratio, 6.72; 95% confidence interval, 2.12e21.30; p ¼ 0.001). 
Discussion
Stroke and the poststroke states are the most significant risk factors for aspiration pneumonia. Thorough preventive and therapeutic strategies have been developed, and appropriate antibiotic use, both pharmacologic and nonpharmacologic approaches for the treatment of poststroke pneumonia, have been rigorously studied. Increases in substance P levels, oral care, and swallowing rehabilitation are necessary to improve the swallowing function in poststroke patients, resulting in a reduction in the incidence of poststroke pneumonia at a chronic stage. Therefore, stroke is a cause of aspiration pneumonia.
14 Table 4 Cox regression analysis for predictor of 30-day mortality.
Variables
Hazard ratio 95% confidence intervals Although stroke-associated pneumonia is frequently encountered and has a significantly deleterious effect on clinical outcomes, there is no useful predictive investigative tool for this clinical entity. For community-acquired pneumonia, PSI and CURB-65 have been well-validated and widely used in severity classification, and many clinicians use them as a guide to appropriately manage patients with community-acquired pneumonia. We found that patients with a semi-coma status (GCS <9), higher CURB-65 score, and unstable hemodynamic status had worse short-term survival.
There is a strong rationale for investigating the efficacy of preventive antibiotics in patients with acute stroke. Antibiotics can be used after acute stroke to prevent infection and may also offer neuroprotection. To prevent infections, the antimicrobial spectrum should cover the most common causative bacteria of pneumonia and urinary tract infections. Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Enterobacteriaceae predominate in patients with aspiration pneumonia, and occur within 4 days after admission (community-acquired aspiration syndrome). 15 In our study, the predominant etiology responsible for poststroke pneumonia was Gram-negative bacilli (K. pneumoniae, Pseudomonas aeruginosa, and Escherichia coli). In a study by Hassan et al, Gram-negative bacilli such as P. aeruginosa (12%) and K. pneumoniae (4%) were, for the most part, the causative microorganisms in strokeassociated pneumonia. 16 For this reason, the initial choice of empirical antibiotics may be based on nosocomial infection.
Although the aspiration of oropharyngeal secretion is considered to be the major pathogenesis of strokeassociated pneumonia, 17 we did not find that initial antibiotics with anaerobic coverage improved 30-day mortality. Anaerobic pathogens were also infrequently isolated from sputum, pleural fluid or blood in a previous clinical survey. 16 There are several limitations to our study. One major limitation is the relatively small sample size and the retrospective nature. Second, some potential biomarkers that predict the outcome of pneumonia, such as the serum procalcitonin level, 18 were not used in this study. Another limitation of the study is that these prognostic factors should be validated in another stroke patient cohort. Nevertheless, these clinical factors may be used to guide treatment strategy, including intensive care, mechanical ventilation, and administration of broad-spectrum antibiotics.
In conclusion, pneumonia is a severe complication of acute ischemic stroke. Once pneumonia develops, an immediate assessment of the GCS, CURB-65 score, and hemodynamic status may help to predict the short-term outcomes.
